| |
Latest 10 SEC filings (by transaction date) for CYTK within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
May 7/24 | May 7/24 | Malik Fady Ibraham | Direct Ownership | Incentive Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -14,186 | |
May 7/24 | May 7/24 | Malik Fady Ibraham | Direct Ownership | Common Stock | S - Open market or private sale | -1,361 | $65.11 |
May 7/24 | May 7/24 | Malik Fady Ibraham | Direct Ownership | Common Stock | S - Open market or private sale | -14,186 | $65.11 |
May 7/24 | May 7/24 | Malik Fady Ibraham | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 14,186 | $6.67 |
Apr 25/24 | Apr 25/24 | Henderson John T | Direct Ownership | Common Stock | S - Open market or private sale | -10,562 | $64.54 |
Apr 15/24 | Apr 12/24 | Malik Fady Ibraham | Direct Ownership | Common Stock | G - Gift | -150 | |
Apr 9/24 | Apr 9/24 | Malik Fady Ibraham | Direct Ownership | Non-Qualified Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -28,605 | |
Apr 9/24 | Apr 9/24 | Malik Fady Ibraham | Direct Ownership | Common Stock | S - Open market or private sale | -4,000 | $74.32 |
Apr 9/24 | Apr 9/24 | Malik Fady Ibraham | Direct Ownership | Common Stock | S - Open market or private sale | -28,605 | $74.31 |
Apr 9/24 | Apr 9/24 | Malik Fady Ibraham | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 28,605 | $6.67 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for CYTK within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
May 7/24 | May 7/24 | Malik Fady Ibraham | Direct Ownership | Incentive Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -14,186 | |
May 7/24 | May 7/24 | Malik Fady Ibraham | Direct Ownership | Common Stock | S - Open market or private sale | -1,361 | $65.11 |
May 7/24 | May 7/24 | Malik Fady Ibraham | Direct Ownership | Common Stock | S - Open market or private sale | -14,186 | $65.11 |
May 7/24 | May 7/24 | Malik Fady Ibraham | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 14,186 | $6.67 |
Apr 25/24 | Apr 25/24 | Henderson John T | Direct Ownership | Common Stock | S - Open market or private sale | -10,562 | $64.54 |
Apr 15/24 | Apr 12/24 | Malik Fady Ibraham | Direct Ownership | Common Stock | G - Gift | -150 | |
Apr 9/24 | Apr 9/24 | Malik Fady Ibraham | Direct Ownership | Non-Qualified Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -28,605 | |
Apr 9/24 | Apr 9/24 | Malik Fady Ibraham | Direct Ownership | Common Stock | S - Open market or private sale | -4,000 | $74.32 |
Apr 9/24 | Apr 9/24 | Malik Fady Ibraham | Direct Ownership | Common Stock | S - Open market or private sale | -28,605 | $74.31 |
Apr 9/24 | Apr 9/24 | Malik Fady Ibraham | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 28,605 | $6.67 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |